Company / Revenue
Steris Revenue History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.5B
FY2024
5-year range
$4.2B / $5.5B
FY2020-FY2024
Trend
+6.2%
vs FY2023
Sector context
#38 of 150
Health Care
What the data says
Steris's revenue of $5.5B is higher than 75% of companies in the Health Care sector (FY2024). Revenue has increased for 7 consecutive years, from $634M in FY2017 to $5.5B in FY2024.
Based on SEC 10-K filings.
$5.5B in FY2024 with a 5-year CAGR of +12.5%. Top quartile in the Health Care sector.
Improved from $4.5B to $5.5B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 150This company $5.5B Sector average $19.5B
▼
-72.0% below sector average
Key checks
Key Insights
- Steris's revenue has grown for 7 consecutive years.
- 5-year CAGR of +12.5%, indicating consistent growth.
- In FY2024, revenue increased 6.2% year-over-year.
- Ranks #38 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $5.5B | +6.2% |
| FY2023 | $5.1B | +13.3% |
| FY2022 | $4.5B | +7.4% |
| FY2021 | $4.2B | +35.9% |
| FY2020 | $3.1B | +2.5% |
| FY2019 | $3.0B | +8.9% |
| FY2018 | $2.8B | +338.7% |
| FY2017 | $634.2M | -75.7% |
| FY2016 | $2.6B | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026